We are live on ! Find out more
CV

Clarus Ventures Portfolio holdings

AUM $425M
1-Year Est. Return 26.13%
This Fund
S&P 500
This Quarter Est. Return
+36.33%
1 Year Est. Return
+26.13%
3 Year Est. Return
+70.29%
5 Year Est. Return
+162.11%
10 Year Est. Return
–
AUM
$425M
AUM Growth
+$144M
Cap. Flow
+$54.7M
Cap. Flow %
12.87%
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GRTS
Gritstone bio, Inc. Common Stock
GRTS
+$36.6M
2
ETTX
Entasis Therapeutics Holdings Inc.
ETTX
+$17.1M
3
NSTG
NanoString Technologies, Inc.
NSTG
+$1.12M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECX
1
Tectonic Therapeutic
TECX
$717M
$154M 36.11%
246,860
– –
NSTG
2
DELISTED
NanoString Technologies, Inc.
NSTG
$72M 16.91%
4,036,025
+76,585
+2% +$1.12M
SIEN
3
DELISTED
Sientra, Inc.
SIEN
$65.2M 15.33%
273,077
– –
FTSV
4
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$56.9M 13.38%
3,816,951
– –
GRTS
5
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$36.6M 8.59%
+2,567,445
New +$36.6M
ETTX
6
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$17.7M 4.15%
+1,623,405
New +$17.1M
VERO
7
DELISTED
Venus Concept
VERO
$10.4M 2.43%
1,442
– –
VBIV
8
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$6.51M 1.53%
89,701
– –
EPIX
9
DELISTED
ESSA Pharma
EPIX
$5.01M 1.18%
1,668,560
– –
ATXS
10
DELISTED
Astria Therapeutics
ATXS
$1.61M 0.38%
33,470
– –

Similar funds

LLC
Latimer Light Capital New York $432M AUM 25.5% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return
SPC
Salient Private Client Houston, Texas $513M AUM 10.97% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
CG
Clinton Group New York $279M AUM 4.76% 1-Year Est. Return
AAM
Amerigo Asset Management George Town, Cayman Islands $254M AUM 115.73% 1-Year Est. Return
SE
Summit Equities Parsippany, New Jersey $601M AUM 9.74% 1-Year Est. Return
CA
Cynosure Advisors Salt Lake City, Utah $238M AUM 4% 1-Year Est. Return

Clarus Ventures's Q3 2018 Portfolio in Review

As of Q3 2018, Clarus Ventures held 10 positions worth $425M, up 51% from $281M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Clarus Ventures deployed $54.7M of net new capital in Q3 2018, opening 2 new positions and adding to 1 existing holding. Its largest new stake was Gritstone bio, Inc. Common Stock: 2,567,445 shares worth $36.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Clarus Ventures's largest Q3 2018 buy was Gritstone bio, Inc. Common Stock: 2,567,445 shares worth $36.6M.
  • Clarus Ventures added most to NanoString Technologies, Inc. in Q3 2018, an estimated $1.12M increase.
  • Clarus Ventures's ten largest holdings make up 100% of its $425M portfolio in Q3 2018.
  • Clarus Ventures opened 2 new positions and closed 0 in Q3 2018.
  • Clarus Ventures's portfolio value rose 51% quarter-over-quarter to $425M.

Based on Clarus Ventures's 13F filing for Q3 2018, filed 14 Nov 2018.